LIMK1 and prostate cancer: Recently, Olson's group, when studying the role of LIMK1 in the nuclear translocation of the androgen receptor, showed that pharmacological inhibition of LIMK, using different LIMK inhibitors, induced an increase of acetylated microtubules in prostate cancer cells, indicative of an enhanced microtubule stability [29].